Company Overview

Cardinal Health, Inc. is a U.S.-based healthcare services and products company that operates primarily in the pharmaceutical and medical products distribution industries. The company plays a central role in the healthcare supply chain by distributing branded and generic pharmaceuticals, specialty drugs, and medical and surgical products to a broad range of healthcare providers. Its core customers include hospitals, health systems, retail and mail-order pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

The company’s primary revenue drivers are its Pharmaceutical Segment, which accounts for the majority of consolidated revenue through high-volume drug distribution, and its Medical Segment, which focuses on higher-margin medical, surgical, and laboratory products, including proprietary brands. Cardinal Health is positioned as one of the “big three” pharmaceutical distributors in the United States, alongside McKesson and Cencora, benefiting from scale, long-term customer contracts, and deep integration into provider operations. The company was founded in 1971 as Cardinal Foods and evolved through acquisitions and strategic expansion into a global healthcare services provider, notably accelerating its growth in pharmaceutical distribution during the 1990s and 2000s.

Business Operations

Cardinal Health operates through two reportable business segments: the Pharmaceutical Segment and the Medical Segment. The Pharmaceutical Segment distributes branded, generic, over-the-counter, and specialty pharmaceuticals, as well as nuclear pharmacy services, to retail pharmacies, hospitals, and other healthcare providers, primarily in the United States. Revenue in this segment is largely volume-driven, with operating income influenced by generic drug pricing dynamics and sourcing economics.

The Medical Segment manufactures, sources, and distributes medical, surgical, and laboratory products, including Cardinal Health Medical Products, which encompass proprietary brands such as exam gloves, gowns, syringes, and infection prevention products. This segment also includes At-Home Solutions, which supplies products and logistics services for home healthcare. International operations are more limited than domestic operations but include medical product distribution and sourcing activities in select global markets. The company maintains long-standing commercial relationships with major pharmacy chains, hospital systems, and group purchasing organizations.

Strategic Position & Investments

Cardinal Health’s strategy emphasizes operational efficiency, disciplined capital allocation, and strengthening its core distribution businesses while expanding higher-margin medical products and services. Growth initiatives have included investments in automation and digital tools to enhance supply chain reliability, as well as targeted expansion of proprietary medical product offerings to improve profitability and reduce reliance on low-margin distribution volumes.

The company has pursued selective acquisitions and divestitures to refine its portfolio. Notably, Cardinal Health exited certain non-core businesses in recent years, including the divestiture of Cordis, a medical device business, to focus on core pharmaceutical and medical supply operations. Ongoing investments also include specialty pharmaceutical services and nuclear pharmacy capabilities, which serve oncology, cardiology, and other specialized care areas. Emerging focus areas include supply chain resiliency, data-driven inventory management, and supporting care delivery in non-acute and home-based settings.

Geographic Footprint

Cardinal Health is headquartered in Dublin, Ohio, and generates the majority of its revenue in North America, particularly the United States, where its pharmaceutical distribution network is nationwide. The company operates a dense network of distribution centers, nuclear pharmacies, and logistics facilities that support next-day or same-day delivery to healthcare providers across the country.

Internationally, Cardinal Health has a more modest footprint, with medical product sourcing, manufacturing, and distribution operations in parts of Europe, Asia-Pacific, and other select global markets. While international operations contribute a smaller share of total revenue, they support global sourcing strategies and provide exposure to international healthcare demand, particularly in medical consumables.

Leadership & Governance

Cardinal Health is led by an executive team focused on operational execution, regulatory compliance, and long-term value creation in a highly regulated industry. Leadership emphasizes supply chain reliability, customer trust, and disciplined financial management, shaped in part by the company’s experience navigating pharmaceutical pricing pressures and opioid-related legal settlements.

Key executives include:

• Jason Hollar – Chief Executive Officer
• Derek Spencer – Chief Financial Officer
• Aaron Alt – Chief Operating Officer
• Robert P. White – President, Medical Segment
• Brian Hainline – Executive Vice President, Pharmaceutical Segment

The company is governed by a board of directors with experience across healthcare, finance, and operations, and management strategy is closely aligned with compliance obligations and risk oversight given Cardinal Health’s role in the regulated pharmaceutical supply chain.